BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29175800)

  • 1. Report: Computational drug designing of newly synthesized triazoles against potential targets of methicillin resistant Staphylococcus aureus.
    Ilyas U; Altaf R; Muhammad SA; Qadir MI; Nadeem H; Ahmed S
    Pak J Pharm Sci; 2017 Nov; 30(6):2271-2279. PubMed ID: 29175800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Shikimate Kinase from Methicillin-Resistant
    Rios-Soto L; Hernández-Campos A; Tovar-Escobar D; Castillo R; Sierra-Campos E; Valdez-Solana M; Téllez-Valencia A; Avitia-Domínguez C
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole "Click" Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA).
    Kumar SV; Scottwell SØ; Waugh E; McAdam CJ; Hanton LR; Brooks HJ; Crowley JD
    Inorg Chem; 2016 Oct; 55(19):9767-9777. PubMed ID: 27657170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
    Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant
    Rios-Soto L; Téllez-Valencia A; Sierra-Campos E; Valdez-Solana M; Cisneros-Martínez J; Gómez Palacio-Gastélum M; Castillo-Villanueva A; Avitia-Domínguez C
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Ge X; Xu Z
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000223. PubMed ID: 32985011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Anti-Bacterial Evaluation of Triazolyl-Pterostilbene Derivatives.
    Tang KW; Yang SC; Tseng CH
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540106
    [No Abstract]   [Full Text] [Related]  

  • 9. 1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Xu Z
    Eur J Med Chem; 2020 Nov; 206():112686. PubMed ID: 32795773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico study of anti-carcinogenic lysyl oxidase-like 2 inhibitors.
    Muhammad SA; Ali A; Ismail T; Zafar R; Ilyas U; Ahmad J
    Comput Biol Chem; 2014 Aug; 51():71-82. PubMed ID: 24703812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-substituted 2-aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1,3-bis(tert-butoxycarbonyl)guanidine cyclization.
    Yeagley AA; Su Z; McCullough KD; Worthington RJ; Melander C
    Org Biomol Chem; 2013 Jan; 11(1):130-7. PubMed ID: 23076976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE.
    Silverman SM; Moses JE; Sharpless KB
    Chemistry; 2017 Jan; 23(1):79-83. PubMed ID: 27747932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Malonamide Derivatives as Antibiotics against Methicillin-Resistant Staphylococcus aureus.
    Su JC; Huang YT; Chen CS; Chiu HC; Shiau CW
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29271946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole-triazole hybrids.
    Negi B; Kumar D; Kumbukgolla W; Jayaweera S; Ponnan P; Singh R; Agarwal S; Rawat DS
    Eur J Med Chem; 2016 Jun; 115():426-37. PubMed ID: 27046397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antibacterial, antielastase, antiurease and antioxidant activities of new methoxy substitued bis-1,2,4-triazole derivatives.
    Sokmen BB; Gumrukcuoglu N; Ugras S; Ugras HI; Yanardag R
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):72-7. PubMed ID: 22085138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
    Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.